Capital Advisors Ltd’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$10K | – | 1586 |
|
|
2025
Q1 | $10K | Buy |
16
+5
| +45% | +$3.13K | ﹤0.01% | 776 |
|
|
2024
Q4 | $8K | Sell |
11
-2
| -15% | -$1.46K | ﹤0.01% | 838 |
|
|
2024
Q3 | $14K | Hold |
13
| – | – | ﹤0.01% | 709 |
|
|
2024
Q2 | $14K | Hold |
13
| – | – | ﹤0.01% | 678 |
|
|
2024
Q1 | $13K | Buy |
13
+2
| +18% | +$2K | ﹤0.01% | 667 |
|
|
2023
Q4 | $10K | Hold |
11
| – | – | ﹤0.01% | 694 |
|
|
2023
Q3 | $9K | Hold |
11
| – | – | ﹤0.01% | 710 |
|
|
2023
Q2 | $8K | Sell |
11
-1
| -8% | -$727 | ﹤0.01% | 739 |
|
|
2023
Q1 | $10K | Buy |
12
+1
| +9% | +$833 | ﹤0.01% | 563 |
|
|
2022
Q4 | $8K | Hold |
11
| – | – | ﹤0.01% | 590 |
|
|
2022
Q3 | $8K | Buy |
+11
| New | +$8K | ﹤0.01% | 574 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | -$1K | – | 1266 |
|
|
2022
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 784 |
|